Showing results (61-70 of 90) with videos related to
Sort By:
Pageof 9
Theranostics|October 14, 2021
The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapyAnais Hagege, Damien Ambrosetti, Julien Boyer, et al.The Journal of Physiology|February 20, 2021
Hypoxia and hypoxia-inducible factors promote the development of neointimal hyperplasia in arteriovenous fistulaNirvana Sadaghianloo, Julie Contenti, Serge Declemy, et al.Genes, Chromosomes & Cancer|August 6, 2021
RBM10-TFE3 fusions: A FISH-concealed anomaly in adult renal cell carcinomas displaying a variety of morphological and genomic features: Comprehensive study of six novel casesIlaria Di Mauro, Bérengère Dadone-Montaudie, Mathilde Sibony, et al.Theranostics|March 9, 2026
Connective tissue growth factor contributes to resistance to anti-angiogenic therapies in renal cancerManon Teisseire, Arthur Karaulic, Julien Parola, et al.Theranostics|August 15, 2019
New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatmentsMaeva Dufies, Oleksandr Grytsai, Cyril Ronco, et al.Cell Reports. Medicine|September 21, 2022
Targeting of c-MET and AXL by cabozantinib is a potential therapeutic strategy for patients with head and neck cell carcinomaAnais Hagege, Esma Saada-Bouzid, Damien Ambrosetti, et al.Theranostics|February 28, 2019
VEGFC acts as a double-edged sword in renal cell carcinoma aggressivenessPapa Diogop Ndiaye, Maeva Dufies, Sandy Giuliano, et al.Oncotarget|March 16, 2018
ATP-competitive Plk1 inhibitors induce caspase 3-mediated Plk1 cleavage and activation in hematopoietic cell linesMaeva Dufies, Damien Ambrosetti, Sonia Boulakirba, et al.EMBO Reports|February 27, 2019
UBTD1 is a mechano-regulator controlling cancer aggressivenessStéphanie Torrino, François-René Roustan, Lisa Kaminski, et al.Urology|June 4, 2021
Active Surveillance for Biopsy Proven Renal Oncocytomas: Outcomes and FeasibilityFrancois-Xavier Deledalle, Damien Ambrosetti, Mathieu Durand, et al.Pageof 9